M. Moore

发表

A Digital Intervention for Primary Care Practitioners to Support Antidepressant Discontinuation (Advisor for Health Professionals): Development Study

C. Dowrick, C. May, J. Moncrieff, 2021, Journal of medical Internet research.

A Digital Intervention for Primary Care Practitioners to Support Antidepressant Discontinuation (Advisor for Health Professionals): Development Study

C. Dowrick, C. May, J. Moncrieff, 2021, Journal of medical Internet research.

Recruitment to a large scale randomised controlled clinical trial in primary care: the Helicobacter Eradication Aspirin Trial (HEAT)

D. Kendrick, C. Hawkey, A. Avery, 2022, Trials.

Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care: the THREAD (THREshold for AntiDepressant re

C. Dowrick, A. Mann, R. Byng, 2009, Health technology assessment.

Cost-effectiveness and cost-utility of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine

Michael J. Campbell, M. Buxton, D. Baldwin, 2006, British Journal of Psychiatry.

Cost-effectiveness and cost-utility of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine

Michael J. Campbell, M. Buxton, D. Baldwin, 2006, British Journal of Psychiatry.

Can oral corticosteroids reduce the severity or duration of an acute cough, and the associated National Health Service and societal costs, in adults presenting to primary care? Study protocol for a randomised controlled trial

D. Kendrick, Matthew J. Thompson, S. Hollinghurst, 2015, Trials.

Maintenance or Discontinuation of Antidepressants in Primary Care.

N. Freemantle, I. Nazareth, S. Gilbody, 2021, The New England journal of medicine.

Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT.

N. Freemantle, I. Nazareth, S. Gilbody, 2021, Health technology assessment.

‘I mean what is depression?’ A qualitative exploration of UK general practitioners’ perceptions of distinctions between emotional distress and depressive disorder

B. Terluin, A. Geraghty, P. Little, 2019, BMJ Open.

Neuropsychological markers of antidepressant action: a secondary analysis of the ANTLER randomised controlled trial

C. Harmer, F. Solmi, L. Duffy, 2023, Psychological Medicine.

Cost-Utility Analysis of Discontinuing Antidepressants in England Primary Care Patients Compared with Long-Term Maintenance: The ANTLER Study

N. Freemantle, G. Lewis, I. Nazareth, 2021, Applied Health Economics and Health Policy.

S0033291722003981jra 1..8

C. Harmer, F. Solmi, L. Duffy, 2023 .

On Behalf of the Osac Trial Team

D. Kendrick, Matthew J. Thompson, S. Hollinghurst, 2022 .

A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine.

Michael J. Campbell, M. Buxton, D. Baldwin, 2005, Health technology assessment.

From non-adaptive depression to general distress

B. Terluin, A. Geraghty, T. Kendrick, 2017, Brain, Behavior, and Immunity.

A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine.

Michael J. Campbell, R. Peveler, M. Moore, 2005, Health technology assessment.

Estimating probability of sustained recovery from mild to moderate depression in primary care: evidence from the THREAD study

C. Dowrick, R. Byng, M. Leese, 2010, Psychological Medicine.